Abstract
A 5-year-old girl with no underlying immune deficiency or hematologic disease was treated with a combination of ceftriaxone and ampicilline-sulbactam for pneumonia. On the ninth day of the therapy, she developed oliguria, paleness, malaise, immune hemolytic anemia (IHA) and acute renal failure (ARF). Laboratory studies showed the presence of antibodies against ceftriaxone. Acute interstitial nephritis (AIN) was diagnosed by renal biopsy. The patient’s renal insufficiency was successfully treated with peritoneal dialysis without any complications. The patient recovered without any treatment using steroids or other immunosuppressive agents.
This is a preview of subscription content, log in via an institution to check access.
References
Bell MJ, Stockwell DC, Luban NL, Shirey RS, Shaak L, Ness PM, Wong EC (2005) Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease. Pediatr Crit Care Med 6(3):363–366
Wells JV, Isbister JP (1991) Hematologic diseases. In: Stites DP, Terr AI (eds) Basic and clinical immunology, 7th edn. Prentice-Hall International, London, 476–491
Arndt PA, Leger RM, Garatty G (1999) Serology of antibodies to second and third generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 39:1239–1246
Garatty G, Arndt PA (1998) Positive direct antiglobulin tests and hemolytic anemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic absorption of protein onto red blood cells. Br J Haematol 100:777–7783
Seltsam A, Salama A (2000) Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 26(9):1390–1394
Petz LD (1993) Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 7(4):242–254
Viner Y, Hashkes PJ, Yakubova R, Segal-Kupershmit D, Luder AS (2000) Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia. Pediatr Infect Dis J 19(1):83–85
Mattis LE, Saavedra JM, Shan H, Shirey RS, Powell E, Oliva-Hemker MM (2004) Life-threatening ceftriaxone-induced immune hemolytic anemia in a child with Crohn’s disease. Clin Pediatr (Phila) 43:175–178
Borgna-Pignatti C, Bezzi TM, Reverberi R (1995) Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 14:1116–1117
Meyer O, Hackstein H, Hoppe B, Gobel FJ, Bein G, Salama A (1999) Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 105:1084–1085
Morin JP, Fillastre JP, Olier B (1984) Antibiotic nephrotoxicity. Chemioterapia 3(1):33–40
Alon US (2004) Tubulointerstitial nephritis. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, 817–831
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demirkaya, E., Atay, A.A., Musabak, U. et al. Ceftriaxone-related hemolysis and acute renal failure. Pediatr Nephrol 21, 733–736 (2006). https://doi.org/10.1007/s00467-006-0043-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0043-4